Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep558 | Diabetes therapy | ECE2016

Dapagliflozin clinical experience and safety on patients with type 2 diabetes and obesity

del Mar Roca-Rodriguez Maria , Picon-Cesar Maria Jose , Omiste-Romero Antonio Jesus , Garcia-Perez Jorge , Aguilar-Diosdado Manuel

Introduction: New treatments of diabetes, such as dapagliflozin, improve global metabolic status beyond glycemic control.Aim: To evaluate tolerance to dapagliflozin and its effects on metabolic control in type 2 diabetes and obese patients attended in endocrinology offices.Material and method: A prospective study of patients with type 2 diabetes and obesity. In an intra-subject analysis, clinical and analytical data were evaluated ...

ea0099ep227 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Amyotrophic lateral sclerosis (als): analysis from a nutritional perspective

Zayas Aguilar Irene , Gonzalez Pachecho Maria , del Mar Roca Rodriguez Maria , Alarcon Manoja Maria , Javier Vilchez Francisco

Introduction: ALS is a neurodegenerative disease with a high prevalence of malnutrition. Nutritional diagnosis is important because of its prognostic implication.Objective: To determine the clinical and morphofunctional characteristics in a series of patients with ALS.Materials and methods: Cross-sectional descriptive study of patients seen at the multidisciplinary ALS clinic of the Hospital Puerta del Mar (Cádiz).<p class...

ea0037ep483 | Diabetes (complications &amp; therapy) | ECE2015

Once-weekly exenatide in a real-world clinical setting: clinical outcomes and analysis of potential predictors of response

del Mar Roca-Rodriguez Maria , Fernandez-Garcia Jose Carlos , Cortes-Salazar Carmen Maria , Moya-Carmona Isabel , Gomez-Perez Ana Maria , Cornejo-Pareja Isabel , Munoz-Garach Araceli , Molina-Vega Maria , Doblas Isabel Mancha , Tinahones Francisco

Objective: The aim of this study is to evaluate the effectiveness of once-weekly exenatide on metabolic control, weight, blood pressure, and lipid profile in obese patients with type 2 diabetes (T2DM), and to assess possible predictive factors of response.Material and methods: Retrospective observational study, conducted with adult obese (BMI ≥30 kg/m2) T2DM subjects that had been initiated once-weekly exenatide following routine clinica...

ea0070ep296 | Pituitary and Neuroendocrinology | ECE2020

Prevalence of hypocortisolism and replacement treatment after transsphenoidal surgery pituitary adenomas

del Mar Roca-Rodriguez Maria , Manuel Cornejo-Domínguez Jesús , Vidal-Suárez Álvaro , Muriel-Cueto Pedro , Iglesias-Lozano Irene , Gavilán-Villarejo Inmaculada , Aguilar-Diosdado Manuel

Aim: Evaluation of hypocortisolism and replacement treatment after transsphenoidal surgery pituitary adenomas and subsequent follow-up in Endocrinology offices.Material and methodWe conducted a retrospective intra-subject study of patients with pituitary adenomas who were undergone surgery. Clinical and analytical data were evaluated at baseline and after surgery between 2012–2018.Results: 30 patients (...

ea0041ep559 | Diabetes therapy | ECE2016

Lixisenatide effects on liver function, lipids and blood pressure levels

del Mar Roca-Rodriguez Maria , Piedrola-Maroto Gonzalo , de Fuentes Maria Teresa Muros , Quesada-Charneco Miguel , Maraver-Selfa Silvia , Tapia-Guerrero M Jose , Cepero-Garcia Daniel , Orduna-Espinosa Rosa , Pechuan-Asensio Joaquin , Ferrandiz-Millon Elena , Galera-Martinez Purificacion , Vazquez-Gutierrez Mercedes , Mancha-Doblas Isabel

Introduction: New diabetes treatments, such as lixisenatide, improve global metabolic status beyond glycemic control.Aim: To evaluate lixisenatide effects on liver function, lipids and blood pressure levels in type 2 diabetes and obese patients attended in endocrinology offices.Material and method: This is a prospective study with a sample of 106 patients with type 2 diabetes and obesity. In an intra-subject analysis, clinical and ...